Next Article in Journal
Differential Expression of DNA Methyltransferase (DNMT1 and DNMT3), Histone Deacetylase (HDAC1 and HDAC2), and Upstream Target Regulators MiR-145 and Mir-152 among Oral Cancers
Previous Article in Journal
Design of Cell-Specific Targeting Peptides for Cancer Therapy
Previous Article in Special Issue
Unit-Emitting Carbon Dots for Cell Imaging and Lipid Droplet Quantification
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Review of Hydrogen Sulfide Based on Its Activity Mechanism and Fluorescence Sensing

by
Jinlong Zhang
1,
Quan Jing
1,2,
Fei Gao
1,2,
Fuxin Zhang
1,2,
Dong Pei
1,
Duolong Di
1 and
Jun Hai
1,*
1
CAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory of Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730099, China
2
University of Chinese Academy of Sciences, Beijing 100049, China
*
Author to whom correspondence should be addressed.
Targets 2024, 2(3), 202-223; https://doi.org/10.3390/targets2030012
Submission received: 27 June 2024 / Revised: 30 July 2024 / Accepted: 6 August 2024 / Published: 7 August 2024
(This article belongs to the Special Issue Fluorescence Imaging of Disease Biomarkers)

Abstract

:
The significance of hydrogen sulfide (H2S) in biological research is covered in detail in this work. H2S is a crucial gas-signaling molecule that is involved in a wide range of illnesses and biological processes. Whether H2S has a beneficial therapeutic effect or negative pathological toxicity in an organism depends on changes in its concentration. A novel approach to treatment is the regulation of H2S production by medications or other measures. Furthermore, H2S is a useful marker for disease assessment because of its dual nature and sensitivity. We can better understand the onset and progression of disease by developing probes to track changes in H2S concentration based on the nucleophilicity, reducing properties, and metal coordination properties of H2S. This will aid in diagnosis and treatment. These results demonstrate the enormous potential of H2S in the detection and management of disease. Future studies should concentrate on clarifying the relationship between diseases and the mechanism of action of H2S in organisms. Ultimately, this work opens new possibilities for disease diagnosis and treatment while highlighting the significance of H2S in biological research. Future clinical practice and medical advancements will benefit greatly from our thorough understanding of the mechanism of action and therapeutic applications of H2S.

1. Introduction

The study of H2S was first prompted by the irritating effects of sewer gas on the eyes, as described in Bernardino Ramazzini’s book “De Morbis Artificum Diatriba” [1], an Italian physician from the 18th century known as the “Father of Occupational Medicine”. It was not until 1775 that the associated product was identified as H2S, despite the fact that Carl Wilhelm Scheele initially created H2S in 1750 by reacting ferrous sulfide with mineral acid [2]. Nonetheless, H2S has been studied primarily for its toxicity since it was discovered centuries ago when it was thought to be a dangerous gas with a rotten egg odor. The discovery of endogenous H2S in animal and human brains by Warenycia [3], Goodwin [4], Savage, and Gould [5] did not lead to the widespread acceptance of H2S as a biological transmitter until the 20th century. H2S was identified as the third gas signal molecule, after carbon monoxide (CO) and nitric oxide (NO), since the ground-breaking research conducted in the late 1990s by Abe and Kimura, who demonstrated that H2S can control nerves and relax blood vessels [6]. Many studies on H2S have advanced quickly in recent years. These studies cover a wide range of topics, such as promoting tissue repair, preventing apoptosis, altering lipid metabolism, stimulating angiogenesis, and inhibiting monocyte adhesion. The pathway of H2S signaling is connected to the physiological changes mentioned above [7,8,9,10,11,12].

2. Endogenous H2S Production

2.1. Enzymatic Pathway

In mammalian tissues, the enzymatic production of endogenous H2S has been extensively studied and is primarily mediated by the following three enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3- MST). Different tissues contain these enzymes, which show different patterns of expression [13]. The liver exhibits the highest level of expression of CSE, which is also highly expressed in the kidneys, neurons, macrophages, and smooth muscle cells [14,15,16,17,18]. The conversion of cysteine into H2S, pyruvate, and ammonia is catalyzed by the expression of CSE. High concentrations of homocysteine can also produce H2S under the catalysis of CSE [19,20,21,22]. Nonetheless, it is generally accepted that the expression and activity of CSE in the heart and spleen are insignificant [23,24]. CBS is mainly expressed in astrocytes in the pancreas, reproductive organs, and brain [25,26,27,28,29]. Research has demonstrated that there is no discernible decrease in the endogenous H2S concentration in the liver of CBS-/-mice when compared to mouse tissue of the wild type [30]. Studies have shown that compared with wild-type mouse tissue, the liver of CBS-/-mice does not show a significant reduction in endogenous H2S concentration [31]. CBS generates H2S through two catalytic pathways. Under CBS catalysis, cysteine will condense with water to generate H2S following β-elimination. Cysteine and homocysteine are directly condensed when catalyzed by CBS to generate cystathionine and H2S [20,32], and 3-MST is mostly present in the cytoplasm and is expressed mainly in the gastrointestinal tract. Additionally, it is expressed in liver, kidney, heart, and brain cells [33,34]. Cysteine and α-ketoglutarate are first catalyzed by cysteine aminotransferase (CAT) into glutamic acid and 3-mercaptopyruvate, and then 3-mercaptopyruvate is converted into H2S and acetone by 3-MST. In addition, 3-MST can form pyruvate and persulfide MST-SSH through 3-mercaptopyruvic acid, which is then triggered by a thiol-containing reducing agent (R-SH) to release H2S (Figure 1) [35,36,37].

2.2. Non-Enzymatic Pathways

Despite the widespread belief that enzymatic H2S production is the primary source of endogenous H2S, Yang and colleagues discovered that non-enzymatic pathways account for the majority of endogenous H2S production in all human tissues, except for the liver and kidney [38]. Their study shows that iron and vitamin B6 catalyze the non-enzymatic production of H2S, with cysteine being the preferred substrate. In addition, thiols or compounds containing thiols can react with other molecules to produce H2S non-enzymatically. Examples of such reactions include a reduction in dietary inorganic sulfide salts or polysulfides by glutathione (GSH) [39,40,41]. This non-enzymatic pathway is widespread in mammals, but its mechanism is poorly understood. A better understanding of non-enzymatic pathways is crucial for further investigation of the physiological role of H2S [42].

3. Metabolism of Endogenous H2S

Research has indicated that the highest possible concentration of endogenous H2S in cells is 0.1 mM, whereas the majority of tissues exhibit a steady-state concentration of endogenous H2S in the nanomolar range [43]. According to kinetic studies, the low steady-state concentration of H2S in tissues results in a higher rate of H2S production and metabolism [44]. When administered in large doses, H2S is rapidly oxidized and excreted as S2O32− and SO42− at tissue-specific rates [45,46]. The metabolism of H2S is mainly carried out through enzymatic pathways. Initially, H2S undergoes oxidation by sulfide quinone oxidoreductase (SQR) within the mitochondrial matrix, resulting in the production of persulfide. This persulfide is subsequently oxidized by ethylmalonic encephalopathy 1 protein (ETHE1), yielding sulfite. Finally, sulfite is further oxidized by sulfite oxidase or rhodenase into SO42− and S2O32− and then excreted in the urine through the kidneys [14].
Unlike enzymatic oxidation, which is a primary mechanism for H2S metabolism, methylation of H2S primarily takes place in the cytoplasm of cells [47]. A small amount of H2S is converted into methylmercaptan and dimethyl sulfide by thiol-S-methyl-transferase (TSMT). Another substrate for rhodanese is dimethyl sulfide, which is oxidized to thio-cyanate and SO42− before being eliminated in the urine.
H2S in the blood can be cleared by metalloproteins (such as hemoglobin, myoglobin, neuroglobin, and cytochrome C oxidase) through the formation of sulfoxide products or metal/disulfide-containing molecules (such as L-glutathione oxidized (GSSG)) [47,48,49,50]. The substance is ultimately eliminated from the body via the kidneys and intestines within a specified timeframe. Very small amounts of H2S are excreted directly from the body in the form of gas from the intestines and lungs (Figure 1).

4. Donor Categories of H2S

The surge of interest in H2S research has led researchers to explore a multitude of H2S donors. To investigate the physiological impacts of endogenous H2S, an appropriate H2S donor needs to have drug-like properties such as stability, low metabolite toxicity, water solubility, and a well-defined release mechanism. This leads to a summary and classification of H2S donors from various sources and release mechanisms based on recent research on H2S donors. By examining these various kinds of H2S donors, we can broaden our perspectives and offer fresh research approaches. There are still many restrictions that prevent the practical application of different types of H2S donors, even though they can address some of the issues that arise in the clinical application of H2S donors. The therapeutic potential of these donors will eventually be realized as H2S research advances.

4.1. Inorganic H2S Donors

H2S gas and sulfide salts (NaHS and Na2S) are the most common ways to study the properties of H2S in biology and are the most direct ways to administer H2S [51,52]. There are still issues with investigating this class of inorganic H2S donors as possible therapeutic agents, although they are frequently used to assess the therapeutic potential of H2S in vitro [53]. When sulfide salt is dissolved in water, it will be hydrolyzed into H2S, HS, and S2− very quickly. This dynamic change makes the quantitative release of H2S from sulfide salts challenging as it lacks targeting capabilities. The most critical issue is that sulfide salts release H2S too quickly, which will cause the H2S content in the blood tissue to rise sharply and then drop rapidly after administration. This is contrary to strictly controlled endogenous H2S release, resulting in the inability to exert a therapeutic effect. The above shortcomings have prompted researchers to explore quantitatively controllable targeted H2S donors.

4.2. Naturally Derived H2S Donors

Garlic has been demonstrated to have positive effects on the cardiovascular system as a naturally occurring product that can release H2S, including lowering blood pressure, lowering cholesterol, preventing platelet aggregation, and preventing oxidative stress [54]. Among them, garlic extract S-allyl-L-cysteine (L-SAC) is a potential source of H2S and is the reason why garlic has cardioprotective effects [55,56,57]. Allicin is also the most common garlic extract, which can be broken down to form diallyl disulfide (DADS), diallyl sulfide (DAS), and diallyl trisulfide (DATS) [58]. Studies have shown that these decomposition products are similar to sulfide salts. In the presence of free sulfhydryl groups, they are released by red blood cells in the blood and release H2S, which plays a role in relaxing blood vessels [39]. In addition to garlic extract (Figure 2), many natural products are considered to be H2S-releasing donors, such as sulforaphane and Erucin [59,60]. Extracting potential H2S donors from natural products is the most attractive method to researchers, not only because such compounds are easy to obtain but, more importantly, because they are easily absorbed by the human body and have low toxicity. Unfortunately, compared with most synthetic H2S donors, natural H2S donors are generally structurally unsuitable for modification and have many by-products. These shortcomings limit the use of natural H2S donors in in vitro and in vivo studies.

4.3. Hydrolysis-Triggered H2S Donors

Lawesson’s reagent (S-1), a sulfide reagent originally developed as a sulfide reagent, and its derivatives such as GYY4137 (S-2) have been shown to release H2S in aqueous solutions more slowly than sulfide salts [61,62]. JK series compounds can achieve different rates of H2S release at different pH values and are also a method for hydrolysis to trigger the release of H2S [63]. 1,2-dithio-3-thiones (DTTs, S-3) are a class of H2S donor compounds that are generally considered to be hydrolysis-triggering [64]. Secondly, a derivative of the DTT compound noranitrisulfide (ADT-OH, S-4) is also worth noting [65]. It is biologically active on its own, and the compound is often derivatized and linked to other drugs to create H2S donor forms of those drugs. At present, according to the activity of ADT and other DTT derivatives that have been studied, the activity of these drugs is closely related to H2S-releasing ability. In addition to developing organic donors of H2S released by hydrolysis, the inorganic H2S donor TTM (S-5) was initially used as a thiol transfer agent in organic synthesis (Figure 3), but under physiological conditions, it can also release H2S by hydrolysis [66].

4.4. Thiol-Triggered H2S Donors

The most common cause of endogenous H2S production is cysteine. Two common cellular nucleophiles and reducing agents that are essential for preserving cellular redox homeostasis are cysteine and glutathione. Additionally, they are thought to activate a variety of bioactive substances, including prodrugs and donors of H2S [67]. Studying these thiol-triggered H2S donors (S-6–S-12) is useful for creating H2S-targeted medications since cysteine and glutathione are expressed and enriched in specific tissues under physiological and pathological circumstances (Figure 4) [68,69,70,71,72,73,74].

4.5. Light-Triggered H2S Donors

Compared with other types of H2S donors, light-triggered donors have “on–off” characteristics that completely rely on external light sources, making them bio-orthogonal, non-invasive, cheap, and practical [75]. As an external stimulus, light irradiation can achieve controllable H2S release by adjusting relevant parameters. The most critical aspect is that the spatiotemporal control characteristics of release at specific locations can reduce off-target effects during delivery and will not be interfered with by a large number of surrounding biologically active substances during the release of H2S. This delivery method provides an effective avenue for the development of targeted therapies and diagnostic visualization. Because of the potential application prospects of the controlled release of H2S, the development of photoresponsive H2S donors (S-13–S-17) has received increasing attention (Figure 5) [76,77,78,79,80]. Although light-triggered H2S donors provide a convenient method for H2S release, potential photodamage to tissues also hinders their biological applications.

4.6. Enzyme-Triggered H2S Donors

Enzymes are a vital class of biological catalysts that are produced by cells and found in many different parts of living things. Because of their high specificity and catalytic properties, enzymes facilitate chemical reactions within organisms with remarkable efficiency and precision under exceedingly mild conditions. Enzyme specificity can be used to target H2S release because particular enzymes can act on structurally similar substrates and are found in particular tissues. Moreover, abnormal up-regulation of specific enzymes is a common accompanying feature of many diseases, supporting the selectivity of enzyme-triggered donors for specific diseases. In other words, an enzyme-triggered H2S donor can precisely release H2S in targeted tissues. Above all, using an enzyme activation strategy does not cause cellular thiols—which are essential for preserving intracellular redox balance—to be depleted. The targeted delivery of H2S (S-18–S-22) through enzyme triggering is therefore a reasonable and practical strategy (Figure 6) [81,82,83,84,85].

4.7. Reactive Oxygen Species-Triggered H2S Donor

Reactive oxygen species (ROS) can influence different signaling pathways within organisms; however, an overabundance of ROS can result in oxidative damage, which can cause cell dysfunction or even death [86]. Numerous illnesses, including cancer, diabetes, cardiovascular disease, neurodegenerative diseases, and aging, are strongly linked to oxidative stress brought on by ROS [87,88,89]. On the other hand, diseases associated with oxidative damage mediated by ROS can be fought off by the reduction protection mechanism of H2S [90,91,92]. The generation of H2S donors in response to ROS has the dual potential to both lower ROS concentration and enhance H2S’s antioxidant properties, ultimately serving to protect cells. Despite this, there are currently very few ROS-triggered H2S donors available, and cell-level research is the only area of study. On the other hand, it is somewhat anticipated that the creation of ROS-triggered H2S donors (S-23, S-24) will offer a new approach to diagnosis and treatment for a variety of illnesses (Figure 7) [93,94,95,96,97,98].

5. Physiological Activity of Endogenous H2S

5.1. Antioxidative Stress

Oxidative stress is defined as cellular or molecular damage brought on by ROS-related enzyme deficiencies and a deficiency in antioxidants [99]. Overproduction of reactive oxygen species (ROS) in cells and tissues can cause misfolded proteins, organelle damage, DNA damage, and dysfunction of neuronal synapses [100,101]. H2S safeguards cells from oxidative stress-induced damage via two distinct mechanisms. Most importantly, it can indirectly mitigate oxidative stress by controlling pathways linked to antioxidants, in addition to its inherent reducing abilities that can eliminate excess ROS [102,103,104,105].
Nrf2 (nuclear factor E2-related factor-2) is a member of the NF-E2 family of transcription factors, playing a crucial role in the regulation of gene expression for various enzymes. This includes its function in mitigating oxidative stress [106]. Nrf2 serves a pivotal function in the oxidative stress response in mammals [107]. This regulation is facilitated by the binding of Nrf2 to antioxidant response elements, cis-regulatory elements, or enhancer sequences. These elements are situated in the promoter regions of specific genes, such as heme oxygenase-1 (HO-1), thioredoxin (Trx), glutathione S-transferase (GST), glutathione passase oxidase (GPx), trioxiredoxin reductase (TrxR) and catalase, etc. [108,109]. Calvert et al. showed that H2S donors can play an anti-oxidative stress role by activating the Nrf2-ROS-AMPK signaling pathway and up-regulating endogenous antioxidants (such as glutathione (GSH)) [110]. SR-A is expressed on the plasma membrane and Golgi apparatus of macrophages and is a clearance receptor for type A macrophages. This process enhances the host’s innate immune response by modulating the direct phagocytosis of pathogenic bacteria and recognizing a variety of pathogen-related molecular patterns [111]. The primary significance of SR-A is its potential as a cytokine that modulates oxidative stress and the associated inflammation [112,113]. Kobayashi et al. reported that the expression of SR-A in the lungs can inhibit the production of pro-inflammatory cytokines to reduce macrophage activation and prevent oxidative stress [114]. Glutathione is the main antioxidant that defends cells against oxidative stress. H2S can increase the production of intracellular glutathione to improve cell vitality [115,116]. Within this context, it is important to note that H2S does not impede the transport of GSH from the cytoplasm to mitochondria. However, it can effectively reallocate GSH to these organelles. Additionally, reactive oxygen species (ROS) are primarily generated within mitochondria. This H2S promotes an increase in GSH in mitochondria and may protect cells from oxidative stress [105].

5.2. Anti-Inflammatory

As an important component of inflammation, excessive accumulation of ROS has always existed in inflammatory tissues within the body [117]. The resulting oxidative stress is also one of the important ways in which inflammation causes damage to tissues and organs. Nitric oxide synthase (iNOS) increases NO content in the early stages of inflammation due to oxidative stress, which, in turn, stimulates the production of NADPH oxidase by phagocytes and superoxide (O2−) by endothelial cells. This promotes the interaction between NO and O2− to form peroxynitrite (ONOO), and catalyzes hydrogen peroxide (H2O2) to produce hypochlorous acid (HOCl) by myeloperoxidase (MPO) in neutrophils. These reactive intermediates not only destroy cells but also damage surrounding tissues and cause more severe inflammatory reactions. In vitro experiments have shown that exogenous H2S-releasing molecules (Na2S and NaSH) can significantly inhibit intracellular HOCl-induced protein oxidation and thereby inhibit cell damage [52,118]. It has been reported that NaSH can scavenge and degrade lipid peroxides [119,120] and significantly inhibit the expression and activity of NADPH oxidase [121,122]. By directly scavenging a range of ROS and indirectly suppressing the expression of associated enzymes, endogenous H2S can prevent the occurrence of oxidative stress and may even have anti-inflammatory properties.
By regulating inflammation-related cytokines, H2S not only reduces inflammation brought on by oxidative stress but also suppresses the inflammatory response in mammals. Pro-inflammatory cytokines initiate and exacerbate inflammation during the body’s inflammatory response, whereas anti-inflammatory cytokines can prevent inflammation from occurring. Studies have shown that endogenous H2S can significantly reduce the content of the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) in plasma interleukin-1 (IL-1) and increase the content of the anti-inflammatory cytokine plasma interleukin-10 (IL-10) in the inflammatory response, thereby producing an anti-inflammatory effect [123]. Lipopolysaccharides (LPSs) induce a significant build-up of neutrophils in tissues during the inflammatory response in the body. According to research, endogenous H2S can significantly reduce the accumulation of neutrophils in tissues (lung and liver), thereby inhibiting the occurrence of inflammatory responses. It is noteworthy that the majority of inflammatory responses involve leukocyte adhesion as a critical component. However, studies have found that endogenous H2S can suppress leukocyte adhesion during the inflammatory response in a concentration-dependent manner, as well as suppress the expression of adhesion factors on leukocytes and endothelial cells [124]. A suitable concentration of exogenous H2S administered to rats in a foot swelling model has been shown to lessen the degree of foot swelling significantly in rats, and it has also been discovered that exogenous H2S donors can significantly inhibit leukocyte adhesion at the inflammatory site [125].

5.3. Protection against Myocardial Damage

Studies reveal that the excessive production of ROS is the primary cause of myocardial injury following ischemic reperfusion. Oxidative stress can cause DNA strand breaks, oxidize proteins to an inactive state, and stimulate lipid peroxidation [126]. The capacity of cardiomyocytes to activate and induce protective enzymes is a prerequisite for maintaining homeostatic characteristics during oxidative stress [127]. H2S has been found to inhibit the production of reactive oxygen species (ROS), the activation of nuclear factor kappa B (NF-kB), the elevation in the expression of cell adhesion factors, and the induction of apoptosis. These are all significant contributors to myocardial injury [97,128]. This may also be a potential mechanism by which H2S reduces arterial plaque and attenuates atherosclerotic damage. Studies have shown that exogenous H2S can exert a cardioprotective effect by increasing cell viability [129]. More specifically, H2S enhances the signaling of Nrf2 and promotes the phosphorylation of both signal transducer and activator of transcription 3 (STAT-3) and protein kinase C epsilon (PKCe). Furthermore, H2S stimulates the expression of heme oxygenase-1 (HO-1), thioredoxin-1 (trx-1), Bcl-2, Bcl-xL, and cyclooxygenase-2 (COX-2) [110]. In cultured cardiomyocytes, NaHS has been observed to exert a concentration-dependent inhibitory effect on apoptosis induced by hypoxia/reoxygenation [130]. Furthermore, NaHS significantly enhances cell viability, increases the proportion of rod cells, and improves myocyte contractility [131]. All of the above indicate that H2S can exert myocardial protection through different pathways.

5.4. Related to Liver Disease

The liver is widely recognized for its pivotal role in the synthesis and clearance of H2S, as well as in the metabolism of carbohydrates and fats. Additionally, it plays a significant part in the excretion of xenobiotics and the host’s defense against harmful microbes. Thus, it is extremely important from a pathological standpoint to investigate how H2S contributes to the onset of liver diseases [132,133,134,135]. H2S production and signaling in the liver are altered in several liver diseases, including liver ischemia/reperfusion (I/R) injury [136], non-alcoholic steatohepatitis (NASH) [137], liver fibrosis [138], and liver cancer [139]. However, the cellular and molecular mechanisms of H2S-mediated liver function have not been fully elucidated. Insufficient endogenous H2S production is closely related to NASH and liver fibrosis, and the role of H2S in liver I/R injury is still controversial. Furthermore, endogenous H2S production or lower exogenous H2S may contribute to the development of liver cancer, while exposure to high amounts of H2S may exhibit anticancer properties. Studies in recent years have shown that H2S plays a key role in glucose and lipid metabolism, circadian rhythm, cell differentiation, and mitochondrial function in the liver [140,141]. A detailed understanding of the exact role and mechanisms of H2S in liver health will greatly advance new potential therapeutic applications of H2S in preclinical and clinical research.

5.5. Related to Cancer

H2S exerts cancer-promoting effects by stimulating mitochondria, promoting angiogenesis, activating anti-apoptotic pathways, and accelerating the cell cycle. In addition, oversulfation of H2S-related proteins is associated with various types of cancer. Three H2S-producing enzymes (CSE, CBS, and 3-MST) were found to be highly expressed [142,143,144]. Among them, CBS can show anti-tumor activity when inhibited, especially in colon cancer, ovarian cancer, and breast cancer; however, whether CSE or 3-MST can produce anti-tumor activity after being inhibited has not been widely studied [8,145,146]. Interestingly, H2S can also induce apoptosis in cancer cells when administered at high concentrations or for long periods in vitro and in vivo without affecting non-cancerous fibroblasts [147]. Consequently, a bell-shaped model can elucidate the role of H2S in cancer development. Specifically, endogenous H2S or relatively low levels of exogenous H2S can manifest carcinogenic effects, whereas high concentrations or prolonged exposure to H2S can induce cancer cell death [148,149]. This observation underscores the fact that inhibiting H2S biosynthesis and supplementing H2S represent two distinctly different therapeutic approaches to cancer. The paradoxical impact of H2S has invigorated interest in the creation of innovative CBS inhibitors, H2S donors, and systems integrating H2S with drugs.

6. Fluorescent Probes for Detecting H2S

Endogenous H2S is a representative material of active sulfur in organisms, and its monitoring is crucial for understanding pathological processes and illness prediction. Many techniques for the in vitro detection of H2S have been developed after years of work, such as gas chromatography, the sulfide ion selective electrode method, electrochemical analysis, and methylene blue spectrophotometry [150]. However, these methods are unsuitable for in vivo detection, which necessitates immediacy, non-invasiveness, and convenience. Fortunately, the H2S fluorescent probe designed in this manner can be extensively utilized in complex and diverse biological environments because of the reducibility, nucleophilicity, and metal coordination chemical properties of H2S [151]. The imaging capabilities of fluorescent probes enable the detection of H2S in organisms, unaffected by physiological tissues and environmental interference. The progression from initial ultraviolet–visible (UV-vis) fluorescence imaging to near-infrared (NIR) fluorescence imaging, and now to the current second region near-infrared fluorescence imaging, has been facilitated by a variety of fluorophores and design strategies. These have ensured sensitivity, accuracy, and detection efficiency. The advancement of microscopy imaging technology has facilitated the progression of H2S detection from a cellular level to an in vivo level, thereby offering a broader scope for exploring the biological functions of H2S. H2S probes are categorized based on their characteristics, which can be encapsulated into several mechanisms such as reduction, nucleophilicity, and metal sulfide.

6.1. Based on Reducibility

As the smallest thiol molecule in biological systems, H2S possesses potent reducing properties. It can effectively reduce chemical groups such as azide, hydroxylamine, and nitro to amino groups. By altering the photoelectric characteristics of the probe, fluorescent probes built in this manner can be used to achieve targeted detection. In chemical biology, organic azides have been extensively employed as bioorthogonal functional groups [152]. Upon the attachment of the potent electron-withdrawing azide moiety to the fluorophore in a conjugated manner, the resultant structure adopts an “A-π-A” electronic configuration, characterized by diminished fluorescence emission [153]. Upon reduction of the azide moiety to an amine by H2S, the electron-withdrawing group is transformed into an electron-donating moiety. This transformation leads to the formation of a “D-π-A” electronic structure, which in turn induces an intramolecular charge transfer (ICT) effect (P-1). Consequently, there is a marked enhancement in the fluorescence emission [154].
In addition to the strategy of introducing the reducing properties of H2S into azide-amines, another “turn-on” probe (P-2) based on the reducing properties of H2S was also developed. This type of probe generally has a two-step sensing mechanism. With the reduction of the disulfide by H2S, a new disulfide is generated. This newly formed disulfide then undergoes partial cyclization with benzoic acid. The resultant cyclized benzoic acid-disulfide structure acts as a self-sacrificial unit, detaching from the overall probe structure. This detachment leads to the restoration of its original fluorescence [155].
In mild conditions, the nitro group can be reduced to the amino group (P-3) by H2S. This principle forms the basis for loading nitro groups onto fluorophores, which significantly quenches fluorescence because of the photoinduced electron transfer (PET) process. However, when H2S reduces the nitro group to the amino group, thereby destroying its electron-withdrawing ability, the PET process is interrupted and fluorescence is restored. This restoration facilitates detection [156].
In addition to the nitro group, the sulfonyl group is also capable of undergoing reduction by H2S (P-4). These sulfonyl groups serve as electron-withdrawing elements within PET systems (Figure 8). Upon reduction of the sulfonyl group to a thiol by H2S, the electron-withdrawing element is transformed into an electron-donating element, leading to a significant enhancement in fluorescence [157].

6.2. Based on Nucleophilicity

H2S is a strong nucleophile and exists mainly in the HS form under physiological conditions at pH, thus exhibiting higher nucleophilicity than many other thiols found in living cells [158]. Taking advantage of the characteristics of this nucleophilic reaction, various types of H2S probes have been developed. These probes are usually designed by incorporating electrophilic functions and converting in the presence of H2S to achieve detection purposes. Two main types of nucleophilic strategy H2S probes were developed in recent years, including nucleophilic substitution and nucleophilic addition.
Similar to m-nitrophenol, the 2,4-dinitrophenyl structure acts as an electron-withdrawing group in the PET system and can also cause fluorescence quenching (P-5). The difference is that the 2,4-dinitrophenyl structure is nucleophilically substituted by H2S rather than reduced to the amino group. The most critical aspect is that the nucleophilic substitution selectivity of H2S on 2,4-dinitrophenyl is preferential to other biothiols. H2S cleaves the linkage between 2,4-dinitrophenyl and the fluorophore via a nucleophilic substitution reaction, thereby liberating the fluorophore. This process enables the fluorescence detection of H2S [159].
The 7-Nitro-1,2,3-benzoxadiazole (NBD) structure is a frequently employed H2S nucleophilically substituted electron-withdrawing group. It shares a similar H2S reaction mechanism to that of 2,4-dinitrophenyl (P-6). However, unlike the PET mechanism utilized by 2,4-dinitrophenyl, NBD quenches fluorescence via the FRET effect. The NBD structure is linked to the fluorophore via a piperazine bond, allowing the initial absorption of fluorescence by the NBD structure. In the presence of H2S, the NBD structure is cleaved, and FRET cannot be performed beyond the distance from the fluorophore, resulting in fluorescence recovery [160,161,162].
The halogen, as an electron-withdrawing group, can be directly connected to the conjugated skeleton of the fluorophore. When H2S is present, the electron-withdrawing halogen is replaced and destroys the conjugated ICT system, ultimately leading to fluorescence enhancement and redshift (P-7). This detection mechanism is mainly used in cyanine- or BODIPY-based H2S probes [163].
As a nucleophile, H2S can not only achieve nucleophilic substitution but also nucleophilically add to electrophilic groups, such as alkenyl and aldehyde groups (P-8, P-9) (Figure 9). Based on this chemical reaction, numerous research groups have documented the development of H2S probes utilizing various fluorophores [164,165].

6.3. Based on Metal Coordination

In addition to the H2S probes designed based on chemical reactions, the detection of H2S can also be achieved through the demetallization reaction of metal complexes induced by H2S (P-10). Cu2+ is a fluorescence quencher. In the presence of H2S, it decomplexes from the probe to form CuS, which restores the fluorescence of the probe to achieve the purpose of detection (Figure 10) [166]

6.4. Based on Self-Immolation Reaction

In the latest research, the self-immolation reaction is considered a new method to achieve the functional detection of H2S (P-11) [167]. During this reaction, the self-immolation spacer group is cleaved into carbonyl sulfide, which can then be catalyzed by carbonic anhydrase in the body to generate H2S. Based on previous research, our research group first designed and synthesized a new water-soluble near-infrared fluorescent probe for detecting H2S (P-12) [168]. The design based on the self-immolation structure could more accurately evaluate the process of cell self-repair in pathological processes with the advantage of low toxicity. Then, we synthesized a compensatory fluorescent probe that detects intracellular H2S without consuming H2S through the self-immolation structure, which greatly reduced the toxicity of the probe without affecting its detection performance (P-13) [169]. In addition, we also used self-immolating spacer groups that can release H2S to synthesize new near-infrared fluorescent diagnostic and therapeutic agents and achieved real-time monitoring of the anticancer effect of H2S in vivo through NTR (nitroreductase) activation, clarifying the complex relationship between H2S and cancer (P-14) (Figure 11) [170].
In living systems, hydrogen sulfide (H2S) is intricately linked to a range of sulfur-containing active substances, including homocysteine (Hcy), cysteine (Cys), and glutathione (GSH). These elements form an interconnected network within the body. Hcy serves as an intermediate in the metabolism of methionine to produce Cys, while Cys is the primary substance for aerobic metabolism to generate H2S; GSH is the central substance of cellular sulfur metabolism. For the detection of H2S, it is crucial to achieve specific detection and monitoring of related metabolic transformations. However, multiple molecular events often occur simultaneously during the signal transduction process in living systems. In theory, the use of multiple probes can enable simultaneous visual tracking of these events. However, the introduction of multiple probes can lead to negative factors such as spectral overlap and reaction cross-reaction. Therefore, a single fluorescent probe with superior functions remains the most effective tool for addressing these issues. During the probe-target reaction process, new reaction sites can be constructed simultaneously to distinguish the target further or detect its metabolites, thereby enabling simultaneous visual tracing of multiple metabolic pathways [158,171,172,173].

7. H2S Scavenging Agents

As a gaseous signaling molecule, both up-regulation and down-regulation of H2S will bring about specific biological consequences. However, in recent years, researchers have focused on developing methods to up-regulate H2S in the body and have made great progress, but there have been few attempts to down-regulate H2S in the body. The reason is the lack of effective/specific inhibitors for H2S-generating enzymes. Ming et al. proposed another solution, which is to develop specific scavengers for H2S. In their study, sulfonyl azide-based scavengers were effective in in vitro and in vivo experiments [174]. This type of H2S scavenger will not only become a useful tool for elucidating the biological effects of H2S but also a potential antidote for H2S poisoning.

8. Conclusions and Outlook

This study reviews the importance of H2S in biological research. As a gas signaling molecule, it is involved in the development of various biological processes and diseases. We found that the concentration changes in H2S are closely related to its biological activity. Moderate H2S concentrations can exhibit positive therapeutic activities, such as antioxidant, anti-inflammatory, and cytoprotective effects, which have potential in the treatment of various diseases such as cardiovascular diseases, neurological diseases, and inflammatory diseases. However, we also found that H2S concentrations that are too high or too low may cause negative pathotoxicity and cause damage to cells and tissues. Therefore, regulating H2S concentration has become an important strategy for treating diseases. We can increase or decrease the production of H2S through drugs or other interventions to achieve therapeutic effects. This external intervention provides a new approach to disease treatment. At the same time, we also found that the sensitivity and dual nature of H2S make it an important marker to evaluate disease. We can use the nucleophilicity, reducing property, and metal coordination characteristics of H2S to design probes to monitor changes in H2S concentration. In addition, the synthesis of H2S-related self-immolation structure compounds and the exploration of H2S scavengers provide new research methods for studying the relationship between H2S and diseases and also provide relevant guidance for diagnosing and treating diseases.
Based on these findings, we recognize that H2S has great potential in the diagnosis and treatment of diseases. In the future, we can further explore the mechanism of action of H2S in organisms and gain a deeper understanding of its relationship with diseases. At the same time, we can work on developing more effective treatments involving innovations in drug development, biotechnology, and treatment strategies to achieve more precise and personalized treatment plans and bring greater benefits to patient health. In summary, this study reveals the importance of H2S in biological research and provides new methods and possibilities for the diagnosis and treatment of diseases. Our in-depth research on the mechanism of action and therapeutic applications of H2S provides important guidance and reference for future medical progress and clinical practice.

Author Contributions

J.Z.: literature review, manuscript preparation, and writing—original draft. Q.J. and F.G.: literature review and manuscript preparation. F.Z.: software and data curation. D.D.: project administration. D.P.: funding acquisition. J.H.: writing—review editing and supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This research was financed by the Key R&D Program of Yunnan Province (No. 202203AD150003) and the Yunnan Province Major Scientific and Technological Project (No. 202302AE090007). We gratefully acknowledge the support from the Young Researcher Program of the Lanzhou Institute of Chemical Physics (E304A8SY).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Araujo-Alvarez, J.M.; Trujillo-Ferrara, J.G. De morbis artificum diatriba 1700–2000. Salud Pública de México 2002, 44, 362–370. [Google Scholar] [CrossRef] [PubMed]
  2. Szabo, C. A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator. Biochem. Pharmacol. 2018, 149, 5–19. [Google Scholar] [CrossRef] [PubMed]
  3. Warenycia, M.W.; Goodwin, L.R.; Benishin, C.G.; Reiffenstein, R.; Francom, D.M.; Taylor, J.D.; Dieken, F.P. Acute hydrogen sulfide poisoning: Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem. Pharmacol. 1989, 38, 973–981. [Google Scholar] [CrossRef] [PubMed]
  4. Goodwin, L.R.; Francom, D.; Dieken, F.P.; Taylor, J.D.; Warenycia, M.W.; Reiffenstein, R.; Dowling, G. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: Postmortem studies and two case reports. J. Anal. Toxicol. 1989, 13, 105–109. [Google Scholar] [CrossRef] [PubMed]
  5. Savage, J.; Gould, D. Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 1990, 526, 540–545. [Google Scholar] [CrossRef] [PubMed]
  6. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996, 16, 1066–1071. [Google Scholar] [CrossRef]
  7. Zhao, W.; Wang, R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol.-Heart Circ. Physiol. 2002, 283, H474–H480. [Google Scholar] [CrossRef]
  8. Chakraborty, P.K.; Xiong, X.; Mustafi, S.B.; Saha, S.; Dhanasekaran, D.; Mandal, N.A.; McMeekin, S.; Bhattacharya, R.; Mukherjee, P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget 2015, 6, 37367. [Google Scholar] [CrossRef]
  9. Kanagy, N.L.; Szabo, C.; Papapetropoulos, A. Vascular biology of hydrogen sulfide. Am. J. Physiol.-Cell Physiol. 2017, 312, C537–C549. [Google Scholar] [CrossRef]
  10. Zhao, Z.-Z.; Wang, Z.; Li, G.-H.; Wang, R.; Tan, J.-M.; Cao, X.; Suo, R.; Jiang, Z.-S. Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp. Biol. Med. 2011, 236, 169–176. [Google Scholar] [CrossRef]
  11. Wang, C.; Du, J.; Du, S.; Liu, Y.; Li, D.; Zhu, X.; Ni, X. Endogenous H2S resists mitochondria-mediated apoptosis in the adrenal glands via ATP5A1 S-sulfhydration in male mice. Mol. Cell. Endocrinol. 2018, 474, 65–73. [Google Scholar] [CrossRef] [PubMed]
  12. Ahmad, A.; Szabo, C. Both the H2S biosynthesis inhibitor aminooxyacetic acid and the mitochondrially targeted H2S donor AP39 exert protective effects in a mouse model of burn injury. Pharmacol. Res. 2016, 113, 348–355. [Google Scholar] [CrossRef] [PubMed]
  13. Filipovic, M.R. Persulfidation (S-sulfhydration) and H2S. Handb. Exp. Pharmacol 2015, 230, 29–59. [Google Scholar] [PubMed]
  14. Kabil, O.; Banerjee, R. Enzymology of H2S biogenesis, decay and signaling. Antioxid. Redox Signal. 2014, 20, 770–782. [Google Scholar] [CrossRef] [PubMed]
  15. Badiei, A.; Chambers, S.; Gaddam, R.; Bhatia, M. Cystathionine-γ-lyase gene silencing with siRNA in monocytes/macrophages attenuates inflammation in cecal ligation and puncture-induced sepsis in the mouse. J. Biosci. 2016, 41, 87–95. [Google Scholar] [CrossRef]
  16. Lu, Y.; O’Dowd, B.F.; Orrego, H.; Israel, Y. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine γ-lyase. Biochem. Biophys. Res. Commun. 1992, 189, 749–758. [Google Scholar] [CrossRef] [PubMed]
  17. Tripatara, P.; SA Patel, N.; Collino, M.; Gallicchio, M.; Kieswich, J.; Castiglia, S.; Benetti, E.; Stewart, K.N.; Brown, P.A.; Yaqoob, M.M. Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab. Investig. 2008, 88, 1038–1048. [Google Scholar] [CrossRef] [PubMed]
  18. Dominy, J.E.; Stipanuk, M.H. New roles for cysteine and transsulfuration enzymes: Production of H2S, a neuromodulator and smooth muscle relaxant. Nutr. Rev. 2004, 62, 348–353. [Google Scholar] [CrossRef] [PubMed]
  19. Singh, S.; Banerjee, R. PLP-dependent H2S biogenesis. Biochim. et Biophys. Acta (BBA)-Proteins Proteom. 2011, 1814, 1518–1527. [Google Scholar] [CrossRef]
  20. Singh, S.; Padovani, D.; Leslie, R.A.; Chiku, T.; Banerjee, R. Relative contributions of cystathionine β-synthase and γ-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J. Biol. Chem. 2009, 284, 22457–22466. [Google Scholar] [CrossRef]
  21. Stipanuk, M.H.; Beck, P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 1982, 206, 267–277. [Google Scholar] [CrossRef] [PubMed]
  22. Chiku, T.; Padovani, D.; Zhu, W.; Singh, S.; Vitvitsky, V.; Banerjee, R. H2S biogenesis by human cystathionine γ-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J. Biol. Chem. 2009, 284, 11601–11612. [Google Scholar] [CrossRef] [PubMed]
  23. Giuffrè, A.; Vicente, J.B. Hydrogen sulfide biochemistry and interplay with other gaseous mediators in mammalian physiology. Oxidative Med. Cell. Longev. 2018, 2018, 6290931. [Google Scholar] [CrossRef] [PubMed]
  24. Kuo, M.M.; Kim, D.H.; Jandu, S.; Bergman, Y.; Tan, S.; Wang, H.; Pandey, D.R.; Abraham, T.P.; Shoukas, A.A.; Berkowitz, D.E. MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery. Am. J. Physiol.-Heart Circ. Physiol. 2016, 310, H71–H79. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, J.; Wang, W.; Li, S.; Han, Y.; Zhang, P.; Meng, G.; Xiao, Y.; Xie, L.; Wang, X.; Sha, J. Hydrogen sulfide as a potential target in preventing spermatogenic failure and testicular dysfunction. Antioxid. Redox Signal. 2018, 28, 1447–1462. [Google Scholar] [CrossRef]
  26. Liang, R.; Yu, W.-d.; Du, J.-b.; Yang, L.-j.; Shang, M.; Guo, J.-z. Localization of cystathionine β synthase in mice ovaries and its expression profile during follicular development. Chin. Med. J. 2006, 119, 1877–1883. [Google Scholar] [CrossRef] [PubMed]
  27. Guzmán, M.A.; Navarro, M.A.; Carnicer, R.; Sarría, A.J.; Acín, S.; Arnal, C.; Muniesa, P.; Surra, J.C.; Arbonés-Mainar, J.M.; Maeda, N. Cystathionine β-synthase is essential for female reproductive function. Hum. Mol. Genet. 2006, 15, 3168–3176. [Google Scholar] [CrossRef] [PubMed]
  28. Miyamoto, R.; Otsuguro, K.-i.; Yamaguchi, S.; Ito, S. Neuronal regulation of expression of hydrogen sulfide-producing enzyme cystathionine β-synthase in rat spinal cord astrocytes. Neurosci. Res. 2015, 97, 52–59. [Google Scholar] [CrossRef]
  29. Lee, M.; Schwab, C.; Yu, S.; McGeer, E.; McGeer, P.L. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol. Aging 2009, 30, 1523–1534. [Google Scholar] [CrossRef] [PubMed]
  30. Szabó, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 2007, 6, 917–935. [Google Scholar] [CrossRef]
  31. Mustafa, A.K.; Gadalla, M.M.; Snyder, S.H. Signaling by gasotransmitters. Sci. Signal. 2009, 2, re2. [Google Scholar] [CrossRef] [PubMed]
  32. Chen, X.; Jhee, K.-H.; Kruger, W.D. Production of the neuromodulator H2S by cystathionine β-synthase via the condensation of cysteine and homocysteine. J. Biol. Chem. 2004, 279, 52082–52086. [Google Scholar] [CrossRef] [PubMed]
  33. Taniguchi, S.; Kang, L.; Kimura, T.; Niki, I. Hydrogen sulphide protects mouse pancreatic β-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br. J. Pharmacol. 2011, 162, 1171–1178. [Google Scholar] [CrossRef] [PubMed]
  34. Fräsdorf, B.; Radon, C.; Leimkühler, S. Characterization and interaction studies of two isoforms of the dual localized 3-mercaptopyruvate sulfurtransferase TUM1 from humans. J. Biol. Chem. 2014, 289, 34543–34556. [Google Scholar] [CrossRef] [PubMed]
  35. Nagahara, N.; Ito, T.; Kitamura, H.; Nishino, T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: Confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis. Histochem. Cell Biol. 1998, 110, 243–250. [Google Scholar] [CrossRef] [PubMed]
  36. Shibuya, N.; Mikami, Y.; Kimura, Y.; Nagahara, N.; Kimura, H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 2009, 146, 623–626. [Google Scholar] [CrossRef] [PubMed]
  37. Shibuya, N.; Koike, S.; Tanaka, M.; Ishigami-Yuasa, M.; Kimura, Y.; Ogasawara, Y.; Fukui, K.; Nagahara, N.; Kimura, H. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat. Commun. 2013, 4, 1366. [Google Scholar] [CrossRef] [PubMed]
  38. Yang, J.; Minkler, P.; Grove, D.; Wang, R.; Willard, B.; Dweik, R.; Hine, C. Non-enzymatic hydrogen sulfide production from cysteine in blood is catalyzed by iron and vitamin B6. Commun. Biol. 2019, 2, 194. [Google Scholar] [CrossRef] [PubMed]
  39. Benavides, G.A.; Squadrito, G.L.; Mills, R.W.; Patel, H.D.; Isbell, T.S.; Patel, R.P.; Darley-Usmar, V.M.; Doeller, J.E.; Kraus, D.W. Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. USA 2007, 104, 17977–17982. [Google Scholar] [CrossRef]
  40. DeLeon, E.R.; Stoy, G.F.; Olson, K.R. Passive loss of hydrogen sulfide in biological experiments. Anal. Biochem. 2012, 421, 203–207. [Google Scholar] [CrossRef]
  41. Powell, C.R.; Dillon, K.M.; Matson, J.B. A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications. Biochem. Pharmacol. 2018, 149, 110–123. [Google Scholar] [CrossRef] [PubMed]
  42. Shen, X.; Carlström, M.; Borniquel, S.; Jädert, C.; Kevil, C.G.; Lundberg, J.O. Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic. Biol. Med. 2013, 60, 195–200. [Google Scholar] [CrossRef]
  43. Furne, J.; Saeed, A.; Levitt, M.D. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2008, 295, R1479–R1485. [Google Scholar] [CrossRef] [PubMed]
  44. Vitvitsky, V.; Kabil, O.; Banerjee, R. High turnover rates for hydrogen sulfide allow for rapid regulation of its tissue concentrations. Antioxid. Redox Signal. 2012, 17, 22–31. [Google Scholar] [CrossRef] [PubMed]
  45. Curtis, C.; Bartholomew, T.; Rose, F.; Dodgson, K. Detoxication of sodium 35S-sulphide in the rat. Biochem. Pharmacol. 1972, 21, 2313–2321. [Google Scholar] [CrossRef] [PubMed]
  46. Bartholomew, T.C.; Powell, G.M.; Dodgson, K.S.; Curtis, C.G. Oxidation of sodium sulphide by rat liver, lungs and kidney. Biochem. Pharmacol. 1980, 29, 2431–2437. [Google Scholar] [CrossRef] [PubMed]
  47. Donnarumma, E.; Trivedi, R.K.; Lefer, D.J. Protective actions of H2S in acute myocardial infarction and heart failure. Compr. Physiol. 2011, 7, 583–602. [Google Scholar]
  48. Vitvitsky, V.; Yadav, P.K.; Kurthen, A.; Banerjee, R. Sulfide oxidation by a noncanonical pathway in red blood cells generates thiosulfate and polysulfides. J. Biol. Chem. 2015, 290, 8310–8320. [Google Scholar] [CrossRef]
  49. Bostelaar, T.; Vitvitsky, V.; Kumutima, J.; Lewis, B.E.; Yadav, P.K.; Brunold, T.C.; Filipovic, M.; Lehnert, N.; Stemmler, T.L.; Banerjee, R. Hydrogen sulfide oxidation by myoglobin. J. Am. Chem. Soc. 2016, 138, 8476–8488. [Google Scholar] [CrossRef]
  50. Ruetz, M.; Kumutima, J.; Lewis, B.E.; Filipovic, M.R.; Lehnert, N.; Stemmler, T.L.; Banerjee, R. A distal ligand mutes the interaction of hydrogen sulfide with human neuroglobin. J. Biol. Chem. 2017, 292, 6512–6528. [Google Scholar] [CrossRef]
  51. Wagner, F.; Wagner, K.; Weber, S.; Stahl, B.; Knöferl, M.W.; Huber-Lang, M.; Seitz, D.H.; Asfar, P.; Calzia, E.; Senftleben, U. Inflammatory effects of hypothermia and inhaled H2S during resuscitated, hyperdynamic murine septic shock. Shock 2011, 35, 396–402. [Google Scholar] [CrossRef] [PubMed]
  52. Whiteman, M.; Cheung, N.S.; Zhu, Y.-Z.; Chu, S.H.; Siau, J.L.; Wong, B.S.; Armstrong, J.S.; Moore, P.K. Hydrogen sulphide: A novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem. Biophys. Res. Commun. 2005, 326, 794–798. [Google Scholar] [CrossRef] [PubMed]
  53. Wallace, J.L.; Vong, L.; McKnight, W.; Dicay, M.; Martin, G.R. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 2009, 137, 569–578.e1. [Google Scholar] [CrossRef] [PubMed]
  54. Pluth, M.D.; Bailey, T.S.; Hammers, M.D.; Hartle, M.D.; Henthorn, H.A.; Steiger, A.K. Natural products containing hydrogen sulfide releasing moieties. Synlett 2015, 26, 2633–2643. [Google Scholar] [CrossRef]
  55. Rahman, M.S. Allicin and other functional active components in garlic: Health benefits and bioavailability. Int. J. Food Prop. 2007, 10, 245–268. [Google Scholar] [CrossRef]
  56. Rana, S.; Pal, R.; Vaiphei, K.; Sharma, S.K.; Ola, R. Garlic in health and disease. Nutr. Res. Rev. 2011, 24, 60–71. [Google Scholar] [CrossRef]
  57. Butt, M.S.; Sultan, M.T.; Butt, M.S.; Iqbal, J. Garlic: Nature’s protection against physiological threats. Crit. Rev. Food Sci. Nutr. 2009, 49, 538–551. [Google Scholar] [CrossRef]
  58. Brodnitz, M.H.; Pascale, J.V.; Van Derslice, L. Flavor components of garlic extract. J. Agric. Food Chem. 1971, 19, 273–275. [Google Scholar] [CrossRef]
  59. Guo, W.; Cheng, Z.-y.; Zhu, Y.-z. Hydrogen sulfide and translational medicine. Acta Pharmacol. Sin. 2013, 34, 1284–1291. [Google Scholar] [CrossRef]
  60. Citi, V.; Martelli, A.; Testai, L.; Marino, A.; Breschi, M.C.; Calderone, V. Hydrogen sulfide releasing capacity of natural isothiocyanates: Is it a reliable explanation for the multiple biological effects of Brassicaceae? Planta Medica 2014, 80, 610–613. [Google Scholar] [CrossRef] [PubMed]
  61. Ozturk, T.; Ertas, E.; Mert, O. Use of Lawesson’s reagent in organic syntheses. Chem. Rev. 2007, 107, 5210–5278. [Google Scholar] [CrossRef] [PubMed]
  62. Li, L.; Whiteman, M.; Guan, Y.Y.; Neo, K.L.; Cheng, Y.; Lee, S.W.; Zhao, Y.; Baskar, R.; Tan, C.-H.; Moore, P.K. Characterization of a novel, water-soluble hydrogen sulfide–releasing molecule (GYY4137) new insights into the biology of hydrogen sulfide. Circulation 2008, 117, 2351–2360. [Google Scholar] [CrossRef]
  63. Kang, J.; Li, Z.; Organ, C.L.; Park, C.-M.; Yang, C.-T.; Pacheco, A.; Wang, D.; Lefer, D.J.; Xian, M. pH-controlled hydrogen sulfide release for myocardial ischemia-reperfusion injury. J. Am. Chem. Soc. 2016, 138, 6336–6339. [Google Scholar] [CrossRef] [PubMed]
  64. Caliendo, G.; Cirino, G.; Santagada, V.; Wallace, J.L. Synthesis and biological effects of hydrogen sulfide (H2S): Development of H2S-releasing drugs as pharmaceuticals. J. Med. Chem. 2010, 53, 6275–6286. [Google Scholar] [CrossRef]
  65. Wallace, J.L.; Caliendo, G.; Santagada, V.; Cirino, G.; Fiorucci, S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide–releasing diclofenac derivative in the rat. Gastroenterology 2007, 132, 261–271. [Google Scholar] [CrossRef]
  66. Xu, S.; Yang, C.-T.; Meng, F.-H.; Pacheco, A.; Chen, L.; Xian, M. Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor. Bioorg. Med. Chem. Lett. 2016, 26, 1585–1588. [Google Scholar] [CrossRef]
  67. Zhang, J.; Duan, D.; Song, Z.L.; Liu, T.; Hou, Y.; Fang, J. Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med. Res. Rev. 2021, 41, 342–394. [Google Scholar] [CrossRef]
  68. Zhao, Y.; Wang, H.; Xian, M. Cysteine-activated hydrogen sulfide (H2S) donors. J. Am. Chem. Soc. 2011, 133, 15–17. [Google Scholar] [CrossRef] [PubMed]
  69. Zhao, Y.; Bhushan, S.; Yang, C.; Otsuka, H.; Stein, J.D.; Pacheco, A.; Peng, B.; Devarie-Baez, N.O.; Aguilar, H.C.; Lefer, D.J. Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury. ACS Chem. Biol. 2013, 8, 1283–1290. [Google Scholar] [CrossRef]
  70. Kang, J.; Ferrell, A.J.; Chen, W.; Wang, D.; Xian, M. Cyclic acyl disulfides and acyl selenylsulfides as the precursors for persulfides (RSSH), selenylsulfides (RSeSH), and hydrogen sulfide (H2S). Org. Lett. 2018, 20, 852–855. [Google Scholar] [CrossRef]
  71. Zhao, Y.; Kang, J.; Park, C.-M.; Bagdon, P.E.; Peng, B.; Xian, M. Thiol-activated gem-dithiols: A new class of controllable hydrogen sulfide donors. Org. Lett. 2014, 16, 4536–4539. [Google Scholar] [CrossRef] [PubMed]
  72. Yao, H.; Luo, S.; Liu, J.; Xie, S.; Liu, Y.; Xu, J.; Zhu, Z.; Xu, S. Controllable thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents. Chem. Commun. 2019, 55, 6193–6196. [Google Scholar] [CrossRef] [PubMed]
  73. Barresi, E.; Nesi, G.; Citi, V.; Piragine, E.; Piano, I.; Taliani, S.; Da Settimo, F.; Rapposelli, S.; Testai, L.; Breschi, M.C. Iminothioethers as hydrogen sulfide donors: From the gasotransmitter release to the vascular effects. J. Med. Chem. 2017, 60, 7512–7523. [Google Scholar] [CrossRef] [PubMed]
  74. Severino, B.; Corvino, A.; Fiorino, F.; Luciano, P.; Frecentese, F.; Magli, E.; Saccone, I.; Di Vaio, P.; Citi, V.; Calderone, V. 1, 2, 4-Thiadiazolidin-3, 5-diones as novel hydrogen sulfide donors. Eur. J. Med. Chem. 2018, 143, 1677–1686. [Google Scholar] [CrossRef] [PubMed]
  75. Kumar, A.; Moralès, O.; Mordon, S.; Delhem, N.; Boleslawski, E. Could Photodynamic Therapy Be a Promising Therapeutic Modality in Hepatocellular Carcinoma Patients? A Critical Review of Experimental and Clinical Studies. Cancers 2021, 13, 5176. [Google Scholar] [CrossRef] [PubMed]
  76. Devarie-Baez, N.O.; Bagdon, P.E.; Peng, B.; Zhao, Y.; Park, C.-M.; Xian, M. Light-induced hydrogen sulfide release from “caged” gem-dithiols. Org. Lett. 2013, 15, 2786–2789. [Google Scholar] [CrossRef] [PubMed]
  77. Sharma, A.K.; Nair, M.; Chauhan, P.; Gupta, K.; Saini, D.K.; Chakrapani, H. Visible-light-triggered uncaging of carbonyl sulfide for hydrogen sulfide (H2S) release. Org. Lett. 2017, 19, 4822–4825. [Google Scholar] [CrossRef] [PubMed]
  78. Woods, J.J.; Cao, J.; Lippert, A.R.; Wilson, J.J. Characterization and biological activity of a hydrogen sulfide-releasing red light-activated ruthenium (ii) complex. J. Am. Chem. Soc. 2018, 140, 12383–12387. [Google Scholar] [CrossRef] [PubMed]
  79. Yi, S.Y.; Moon, Y.K.; Kim, S.; Kim, S.; Park, G.; Kim, J.J.; You, Y. Visible light-driven photogeneration of hydrogen sulfide. Chem. Commun. 2017, 53, 11830–11833. [Google Scholar] [CrossRef]
  80. Venkatesh, Y.; Das, J.; Chaudhuri, A.; Karmakar, A.; Maiti, T.K.; Singh, N.P. Light triggered uncaging of hydrogen sulfide (H 2 S) with real-time monitoring. Chem. Commun. 2018, 54, 3106–3109. [Google Scholar] [CrossRef]
  81. Zheng, Y.; Yu, B.; Ji, K.; Pan, Z.; Chittavong, V.; Wang, B. Esterase-sensitive prodrugs with tunable release rates and direct generation of hydrogen sulfide. Angew. Chem. Int. Ed. 2016, 55, 4514–4518. [Google Scholar] [CrossRef] [PubMed]
  82. Shukla, P.; Khodade, V.S.; SharathChandra, M.; Chauhan, P.; Mishra, S.; Siddaramappa, S.; Pradeep, B.E.; Singh, A.; Chakrapani, H. “On demand” redox buffering by H2S contributes to antibiotic resistance revealed by a bacteria-specific H2S donor. Chem. Sci. 2017, 8, 4967–4972. [Google Scholar] [CrossRef] [PubMed]
  83. Chauhan, P.; Bora, P.; Ravikumar, G.; Jos, S.; Chakrapani, H. Esterase activated carbonyl sulfide/hydrogen sulfide (H2S) donors. Org. Lett. 2017, 19, 62–65. [Google Scholar] [CrossRef] [PubMed]
  84. Shyaka, C.; Xian, M.; Park, C.-M. Esterase-sensitive trithiane-based hydrogen sulfide donors. Org. Biomol. Chem. 2019, 17, 9999–10003. [Google Scholar] [CrossRef] [PubMed]
  85. Ni, X.; Li, X.; Shen, T.-L.; Qian, W.-J.; Xian, M. A sweet H2S/H2O2 dual release system and specific protein S-persulfidation mediated by thioglucose/glucose oxidase. J. Am. Chem. Soc. 2021, 143, 13325–13332. [Google Scholar] [CrossRef] [PubMed]
  86. Parvez, S.; Long, M.J.; Poganik, J.R.; Aye, Y. Redox signaling by reactive electrophiles and oxidants. Chem. Rev. 2018, 118, 8798–8888. [Google Scholar] [CrossRef] [PubMed]
  87. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef]
  88. Sies, H.; Jones, D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020, 21, 363–383. [Google Scholar] [CrossRef]
  89. Sies, H. Oxidative eustress: On constant alert for redox homeostasis. Redox Biol. 2021, 41, 101867. [Google Scholar] [CrossRef]
  90. Scammahorn, J.J.; Nguyen, I.T.; Bos, E.M.; Van Goor, H.; Joles, J.A. Fighting oxidative stress with sulfur: Hydrogen sulfide in the renal and cardiovascular systems. Antioxidants 2021, 10, 373. [Google Scholar] [CrossRef]
  91. Yang, X.; Wang, C.; Zhang, X.; Chen, S.; Chen, L.; Lu, S.; Lu, S.; Yan, X.; Xiong, K.; Liu, F. Redox regulation in hydrogen sulfide action: From neurotoxicity to neuroprotection. Neurochem. Int. 2019, 128, 58–69. [Google Scholar] [CrossRef] [PubMed]
  92. Corsello, T.; Komaravelli, N.; Casola, A. Role of hydrogen sulfide in NRF2-and sirtuin-dependent maintenance of cellular redox balance. Antioxidants 2018, 7, 129. [Google Scholar] [CrossRef] [PubMed]
  93. Zhao, Y.; Pluth, M.D. Hydrogen sulfide donors activated by reactive oxygen species. Angew. Chem. 2016, 128, 14858–14862. [Google Scholar] [CrossRef]
  94. Chauhan, P.; Jos, S.; Chakrapani, H. Reactive oxygen species-triggered tunable hydrogen sulfide release. Org. Lett. 2018, 20, 3766–3770. [Google Scholar] [CrossRef] [PubMed]
  95. Liu, Z.; Han, Y.; Li, L.; Lu, H.; Meng, G.; Li, X.; Shirhan, M.; Peh, M.T.; Xie, L.; Zhou, S. The hydrogen sulfide donor, GYY 4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E−/− mice. Br. J. Pharmacol. 2013, 169, 1795–1809. [Google Scholar] [CrossRef] [PubMed]
  96. Mani, S.; Li, H.; Untereiner, A.; Wu, L.; Yang, G.; Austin, R.C.; Dickhout, J.G.; Lhoták, Š.; Meng, Q.H.; Wang, R. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 2013, 127, 2523–2534. [Google Scholar] [CrossRef] [PubMed]
  97. Wang, Y.; Zhao, X.; Jin, H.; Wei, H.; Li, W.; Bu, D.; Tang, X.; Ren, Y.; Tang, C.; Du, J. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 173–179. [Google Scholar] [CrossRef] [PubMed]
  98. Zhang, H.; Guo, C.; Wu, D.; Zhang, A.; Gu, T.; Wang, L.; Wang, C. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS ONE 2012, 7, e41147. [Google Scholar] [CrossRef] [PubMed]
  99. Fransen, M.; Nordgren, M.; Wang, B.; Apanasets, O. Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2012, 1822, 1363–1373. [Google Scholar] [CrossRef]
  100. Kneeshaw, S.; Keyani, R.; Delorme-Hinoux, V.; Imrie, L.; Loake, G.J.; Le Bihan, T.; Reichheld, J.-P.; Spoel, S.H. Nucleoredoxin guards against oxidative stress by protecting antioxidant enzymes. Proc. Natl. Acad. Sci. USA 2017, 114, 8414–8419. [Google Scholar] [CrossRef]
  101. Lv, H.; Liu, Q.; Wen, Z.; Feng, H.; Deng, X.; Ci, X. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 2017, 12, 311–324. [Google Scholar] [CrossRef] [PubMed]
  102. Vandervliet, A.; Eiserich, J.P.; Oneill, C.A.; Halliwell, B.; Cross, C.E. Tyrosine modification by reactive nitrogen species: A closer look. Arch. Biochem. Biophys. 1995, 319, 341–349. [Google Scholar] [CrossRef] [PubMed]
  103. Whiteman, M.; Armstrong, J.S.; Chu, S.H.; Jia-Ling, S.; Wong, B.S.; Cheung, N.S.; Halliwell, B.; Moore, P.K. The novel neuromodulator hydrogen sulfide: An endogenous peroxynitrite ‘scavenger’? J. Neurochem. 2004, 90, 765–768. [Google Scholar] [CrossRef] [PubMed]
  104. Kimura, Y.; Goto, Y.-I.; Kimura, H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 2010, 12, 1–13. [Google Scholar] [CrossRef] [PubMed]
  105. Yang, W.; Yang, G.; Jia, X.; Wu, L.; Wang, R. Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J. Physiol. 2005, 569, 519–531. [Google Scholar] [CrossRef] [PubMed]
  106. Fisher, C.D.; Augustine, L.M.; Maher, J.M.; Nelson, D.M.; Slitt, A.L.; Klaassen, C.D.; Lehman-McKeeman, L.D.; Cherrington, N.J. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metab. Dispos. 2007, 35, 995–1000. [Google Scholar] [CrossRef] [PubMed]
  107. Suzuki, T.; Seki, S.; Hiramoto, K.; Naganuma, E.; Kobayashi, E.H.; Yamaoka, A.; Baird, L.; Takahashi, N.; Sato, H.; Yamamoto, M. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus. Nat. Commun. 2017, 8, 14577. [Google Scholar] [CrossRef] [PubMed]
  108. Tanito, M.; Agbaga, M.-P.; Anderson, R.E. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic. Biol. Med. 2007, 42, 1838–1850. [Google Scholar] [CrossRef]
  109. Zhu, H.; Itoh, K.; Yamamoto, M.; Zweier, J.L.; Li, Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett. 2005, 579, 3029–3036. [Google Scholar] [CrossRef]
  110. Calvert, J.W.; Jha, S.; Gundewar, S.; Elrod, J.W.; Ramachandran, A.; Pattillo, C.B.; Kevil, C.G.; Lefer, D.J. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res. 2009, 105, 365–374. [Google Scholar] [CrossRef]
  111. Xu, Z.; Xu, L.; Li, W.; Jin, X.; Song, X.; Chen, X.; Zhu, J.; Zhou, S.; Li, Y.; Zhang, W. Innate scavenger receptor-A regulates adaptive T helper cell responses to pathogen infection. Nat. Commun. 2017, 8, 16035. [Google Scholar] [CrossRef] [PubMed]
  112. Ozeki, Y.; Tsutsui, H.; Kawada, N.; Suzuki, H.; Kataoka, M.; Kodama, T.; Yano, I.; Kaneda, K.; Kobayashi, K. Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Microb. Pathog. 2006, 40, 171–176. [Google Scholar] [CrossRef]
  113. Beamer, C.A.; Holian, A. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2005, 289, L186–L195. [Google Scholar] [CrossRef] [PubMed]
  114. Kobayashi, H.; Sakashita, N.; Okuma, T.; Terasaki, Y.; Tsujita, K.; Suzuki, H.; Kodama, T.; Nomori, H.; Kawasuji, M.; Takeya, M. Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress. J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2007, 212, 38–46. [Google Scholar] [CrossRef] [PubMed]
  115. Kimura, Y.; Kimura, H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004, 18, 1165–1167. [Google Scholar] [CrossRef] [PubMed]
  116. Kimura, Y.; Dargusch, R.; Schubert, D.; Kimura, H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox Signal. 2006, 8, 661–670. [Google Scholar] [CrossRef] [PubMed]
  117. Pattison, D.J.; Winyard, P.G. Dietary antioxidants in inflammatory arthritis: Do they have any role in etiology or therapy? Nat. Clin. Pract. Rheumatol. 2008, 4, 590–596. [Google Scholar] [CrossRef] [PubMed]
  118. Laggner, H.; Muellner, M.K.; Schreier, S.; Sturm, B.; Hermann, M.; Exner, M.; Laggner, H.; Muellner, M.K.; Schreier, S.; Sturm, B. Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic. Res. 2007, 41, 741–747. [Google Scholar] [CrossRef]
  119. Muellner, M.K.; Schreier, S.M.; Laggner, H.; Hermann, M.; Esterbauer, H.; Exner, M.; Gmeiner, B.M.; Kapiotis, S. Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem. J. 2009, 420, 277–281. [Google Scholar] [CrossRef]
  120. Schreier, S.M.; Muellner, M.K.; Steinkellner, H.; Hermann, M.; Esterbauer, H.; Exner, M.; Gmeiner, B.M.; Kapiotis, S.; Laggner, H. Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox. Res. 2010, 17, 249–256. [Google Scholar] [CrossRef]
  121. Tyagi, N.; Moshal, K.S.; Sen, U.; Vacek, T.P.; Kumar, M.; Hughes Jr, W.M.; Kundu, S.; Tyagi, S.C. H2S protects against methionine–induced oxidative stress in brain endothelial cells. Antioxid. Redox Signal. 2009, 11, 25–33. [Google Scholar] [CrossRef] [PubMed]
  122. Muzaffar, S.; Shukla, N.; Bond, M.; Newby, A.C.; Angelini, G.D.; Sparatore, A.; Del Soldato, P.; Jeremy, J.Y. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J. Vasc. Res. 2008, 45, 521–528. [Google Scholar] [CrossRef] [PubMed]
  123. Li, L.; Rossoni, G.; Sparatore, A.; Lee, L.C.; Del Soldato, P.; Moore, P.K. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med. 2007, 42, 706–719. [Google Scholar] [CrossRef]
  124. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005, 129, 1210–1224. [Google Scholar] [CrossRef]
  125. Zanardo, R.C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J.L.; Zanardo, R.C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006, 20, 2118–2120. [Google Scholar] [CrossRef]
  126. Venardos, K.M.; Kaye, D.M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: A review. Curr. Med. Chem. 2007, 14, 1539–1549. [Google Scholar] [CrossRef]
  127. Kang, K.W.; Lee, S.J.; Kim, S.G. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid. Redox Signal. 2005, 7, 1664–1673. [Google Scholar] [CrossRef]
  128. Pan, L.-L.; Liu, X.-H.; Gong, Q.-H.; Wu, D.; Zhu, Y.-Z. Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS ONE 2011, 6, e19766. [Google Scholar] [CrossRef]
  129. Pan, T.-T.; Feng, Z.-N.; Lee, S.W.; Moore, P.K.; Bian, J.-S. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J. Mol. Cell. Cardiol. 2006, 40, 119–130. [Google Scholar] [CrossRef] [PubMed]
  130. Yao, L.-L.; Huang, X.-W.; Wang, Y.-G.; Cao, Y.-X.; Zhang, C.-C.; Zhu, Y.-C. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP. Am. J. Physiol.-Heart Circ. Physiol. 2010, 298, H1310–H1319. [Google Scholar] [CrossRef]
  131. Hu, L.-F.; Pan, T.-T.; Neo, K.L.; Yong, Q.C.; Bian, J.-S. Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes. Pflügers Arch.-Eur. J. Physiol. 2008, 455, 971–978. [Google Scholar] [CrossRef] [PubMed]
  132. Mani, S.; Cao, W.; Wu, L.; Wang, R. Hydrogen sulfide and the liver. Nitric Oxide 2014, 41, 62–71. [Google Scholar] [CrossRef] [PubMed]
  133. Gao, B.; Jeong, W.I.; Tian, Z. Liver: An organ with predominant innate immunity. Hepatology 2008, 47, 729–736. [Google Scholar] [CrossRef]
  134. Shi, D.; Chen, J.; Wang, J.; Yao, J.; Huang, Y.; Zhang, G.; Bao, Z. Circadian clock genes in the metabolism of non-alcoholic fatty liver disease. Front. Physiol. 2019, 10, 423. [Google Scholar] [CrossRef] [PubMed]
  135. Chen, K.; Zhong, J.; Hu, L.; Li, R.; Du, Q.; Cai, J.; Li, Y.; Gao, Y.; Cui, X.; Yang, X. The role of xenobiotic receptors on hepatic glycolipid metabolism. Curr. Drug Metab. 2019, 20, 29–35. [Google Scholar] [CrossRef] [PubMed]
  136. Kang, K.; Zhao, M.; Jiang, H.; Tan, G.; Pan, S.; Sun, X. Role of hydrogen sulfide in hepatic ischemia-reperfusion–induced injury in rats. Liver Transplant. 2009, 15, 1306–1314. [Google Scholar] [CrossRef] [PubMed]
  137. Li, M.; Xu, C.; Shi, J.; Ding, J.; Wan, X.; Chen, D.; Gao, J.; Li, C.; Zhang, J.; Lin, Y. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut 2018, 67, 2169–2180. [Google Scholar] [CrossRef] [PubMed]
  138. Song, K.; Li, Q.; Yin, X.-Y.; Lu, Y.; Liu, C.-F.; Hu, L.-F. Hydrogen sulfide: A therapeutic candidate for fibrotic disease? Oxidative Med. Cell. Longev. 2015, 2015, 458720. [Google Scholar] [CrossRef]
  139. Yin, P.; Zhao, C.; Li, Z.; Mei, C.; Yao, W.; Liu, Y.; Li, N.; Qi, J.; Wang, L.; Shi, Y. Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell. Signal. 2012, 24, 1229–1240. [Google Scholar] [CrossRef] [PubMed]
  140. Andrade, R.J.; Chalasani, N.; Björnsson, E.S.; Suzuki, A.; Kullak-Ublick, G.A.; Watkins, P.B.; Devarbhavi, H.; Merz, M.; Lucena, M.I.; Kaplowitz, N. Drug-induced liver injury. Nat. Rev. Dis. Primers 2019, 5, 58. [Google Scholar] [CrossRef] [PubMed]
  141. Norris, E.J.; Culberson, C.R.; Narasimhan, S.; Clemens, M.G. The liver as a central regulator of hydrogen sulfide. Shock 2011, 36, 242. [Google Scholar] [CrossRef] [PubMed]
  142. Szabo, C.; Hellmich, M.R. Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation. Cell Cycle 2013, 12, 2915–2916. [Google Scholar] [CrossRef] [PubMed]
  143. Guo, H.; Gai, J.-W.; Wang, Y.; Jin, H.-F.; Du, J.-B.; Jin, J. Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells. Urology 2012, 79, 483.e1–483.e5. [Google Scholar] [CrossRef] [PubMed]
  144. Jurkowska, H.; Placha, W.; Nagahara, N.; Wróbel, M. The expression and activity of cystathionine-γ-lyase and 3-mercaptopyruvate sulfurtransferase in human neoplastic cell lines. Amino Acids 2011, 41, 151–158. [Google Scholar] [CrossRef] [PubMed]
  145. Chao, C.; Zatarain, J.R.; Ding, Y.; Coletta, C.; Mrazek, A.A.; Druzhyna, N.; Johnson, P.; Chen, H.; Hellmich, J.L.; Asimakopoulou, A. Cystathionine-β-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach. Mol. Med. 2016, 22, 361–379. [Google Scholar] [CrossRef] [PubMed]
  146. Bhattacharyya, S.; Saha, S.; Giri, K.; Lanza, I.R.; Nair, K.S.; Jennings, N.B.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Basal, E.; Weaver, A.L. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS ONE 2013, 8, e79167. [Google Scholar] [CrossRef] [PubMed]
  147. Lee, Z.W.; Zhou, J.; Chen, C.-S.; Zhao, Y.; Tan, C.-H.; Li, L.; Moore, P.K.; Deng, L.-W. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE 2011, 6, e21077. [Google Scholar] [CrossRef]
  148. Wu, D.; Li, M.; Tian, W.; Wang, S.; Cui, L.; Li, H.; Wang, H.; Ji, A.; Li, Y. Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Sci. Rep. 2017, 7, 5134. [Google Scholar] [CrossRef]
  149. Wu, D.; Si, W.; Wang, M.; Lv, S.; Ji, A.; Li, Y. Hydrogen sulfide in cancer: Friend or foe? Nitric Oxide 2015, 50, 38–45. [Google Scholar] [CrossRef]
  150. Wang, X.; An, L.; Tian, Q.; Cui, K. Recent progress in H 2 S activated diagnosis and treatment agents. RSC Adv. 2019, 9, 33578–33588. [Google Scholar] [CrossRef]
  151. Lin, V.S.; Chen, W.; Xian, M.; Chang, C.J. Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems. Chem. Soc. Rev. 2015, 44, 4596–4618. [Google Scholar] [CrossRef] [PubMed]
  152. Agard, N.J.; Baskin, J.M.; Prescher, J.A.; Lo, A.; Bertozzi, C.R. A comparative study of bioorthogonal reactions with azides. ACS Chem. Biol. 2006, 1, 644–648. [Google Scholar] [CrossRef] [PubMed]
  153. Yu, C.; Li, X.; Zeng, F.; Zheng, F.; Wu, S. Carbon-dot-based ratiometric fluorescent sensor for detecting hydrogen sulfide in aqueous media and inside live cells. Chem. Commun. 2013, 49, 403–405. [Google Scholar] [CrossRef]
  154. Chen, B.; Li, W.; Lv, C.; Zhao, M.; Jin, H.; Jin, H.; Du, J.; Zhang, L.; Tang, X. Fluorescent probe for highly selective and sensitive detection of hydrogen sulfide in living cells and cardiac tissues. Analyst 2013, 138, 946–951. [Google Scholar] [CrossRef] [PubMed]
  155. Zhang, L.-L.; Zhu, H.-K.; Zhao, C.-C.; Gu, X.-F. A near-infrared fluorescent probe for monitoring fluvastatin-stimulated endogenous H2S production. Chin. Chem. Lett. 2017, 28, 218–221. [Google Scholar] [CrossRef]
  156. Wang, L.; Chen, X.; Cao, D. A nitroolefin functionalized DPP fluorescent probe for the selective detection of hydrogen sulfide. New J. Chem. 2017, 41, 3367–3373. [Google Scholar] [CrossRef]
  157. Wang, R.; Dong, K.; Xu, G.; Shi, B.; Zhu, T.; Shi, P.; Guo, Z.; Zhu, W.-H.; Zhao, C. Activatable near-infrared emission-guided on-demand administration of photodynamic anticancer therapy with a theranostic nanoprobe. Chem. Sci. 2019, 10, 2785–2790. [Google Scholar] [CrossRef]
  158. He, L.; Yang, X.; Xu, K.; Kong, X.; Lin, W. A multi-signal fluorescent probe for simultaneously distinguishing and sequentially sensing cysteine/homocysteine, glutathione, and hydrogen sulfide in living cells. Chem. Sci. 2017, 8, 6257–6265. [Google Scholar] [CrossRef] [PubMed]
  159. Zheng, K.; Lin, W.; Tan, L.; Cheng, D. A two-photon fluorescent probe with a large turn-on signal for imaging hydrogen sulfide in living tissues. Anal. Chim. Acta 2015, 853, 548–554. [Google Scholar] [CrossRef]
  160. Pak, Y.L.; Li, J.; Ko, K.C.; Kim, G.; Lee, J.Y.; Yoon, J. Mitochondria-targeted reaction-based fluorescent probe for hydrogen sulfide. Anal. Chem. 2016, 88, 5476–5481. [Google Scholar] [CrossRef]
  161. Ismail, I.; Wang, D.; Wang, Z.; Wang, D.; Zhang, C.; Yi, L.; Xi, Z. A julolidine-fused coumarin-NBD dyad for highly selective and sensitive detection of H2S in biological samples. Dye. Pigment. 2019, 163, 700–706. [Google Scholar] [CrossRef]
  162. Ismail, I.; Chen, Z.; Sun, L.; Ji, X.; Ye, H.; Kang, X.; Huang, H.; Song, H.; Bolton, S.G.; Xi, Z. Highly efficient H 2 S scavengers via thiolysis of positively-charged NBD amines. Chem. Sci. 2020, 11, 7823–7828. [Google Scholar] [CrossRef]
  163. Wang, F.; Zhang, C.; Qu, X.; Cheng, S.; Xian, Y. Cationic cyanine chromophore-assembled upconversion nanoparticles for sensing and imaging H2S in living cells and zebrafish. Biosens. Bioelectron. 2019, 126, 96–101. [Google Scholar] [CrossRef] [PubMed]
  164. Zhu, J.; Hu, X.; Yang, B.; Liu, B. Dual sites fluorescence probe for hydrogen sulfide: AIEE activity and supramolecular assembly with β-cyclodextrin. Sens. Actuators B Chem. 2019, 282, 743–749. [Google Scholar] [CrossRef]
  165. Ryu, H.G.; Singha, S.; Jun, Y.W.; Reo, Y.J.; Ahn, K.H. Two-photon fluorescent probe for hydrogen sulfide based on a red-emitting benzocoumarin dye. Tetrahedron Lett. 2018, 59, 49–53. [Google Scholar] [CrossRef]
  166. Hu, Y.; Kang, J.; Zhou, P.; Han, X.; Sun, J.; Liu, S.; Zhang, L.; Fang, J. A selective colorimetric and red-emitting fluorometric probe for sequential detection of Cu2+ and H2S. Sens. Actuators B Chem. 2018, 255, 3155–3162. [Google Scholar] [CrossRef]
  167. Steiger, A.K.; Pardue, S.; Kevil, C.G.; Pluth, M. Self-Immolative Thiocarbamates Provide Access to Triggered H2S Donors and Analyte Replacement Fluorescent Probes. J. Am. Chem. Soc. 2016, 138, 7256–7259. [Google Scholar] [CrossRef] [PubMed]
  168. Zhang, J.; Mu, S.; Wang, Y.; Li, S.; Shi, X.; Liu, X.; Zhang, H. A water-soluble near-infrared fluorescent probe for monitoring change of hydrogen sulfide during cell damage and repair process. Anal. Chim. Acta 2022, 1195, 339457. [Google Scholar] [CrossRef] [PubMed]
  169. Zhang, J.; Mu, S.; Wang, W.; Sun, H.; Li, S.; Shi, X.; Liu, Y.; Liu, X.; Zhang, H. Design strategy for an analyte-compensated fluorescent probe to reduce its toxicity. Chem. Commun. 2022, 58, 9136–9139. [Google Scholar] [CrossRef]
  170. Zhang, J.; Han, T.; Sun, H.; Han, Z.; Shi, X.; Gao, J.; Liu, X.; Zhang, H. A self-immolative near-infrared fluorescent probe for identification of cancer cells and facilitating its apoptosis. Anal. Bioanal. Chem. 2024, 416, 1529–1540. [Google Scholar] [CrossRef]
  171. Huang, Y.; Zhang, Y.; Huo, F.; Chao, J.; Cheng, F.; Yin, C. A new strategy: Distinguishable multi-substance detection, multiple pathway tracing based on a new site constructed by the reaction process and its tumor targeting. J. Am. Chem. Soc. 2020, 142, 18706–18714. [Google Scholar] [CrossRef] [PubMed]
  172. Yang, X.; Liu, W.; Tang, J.; Li, P.; Weng, H.; Ye, Y.; Xian, M.; Tang, B.; Zhao, Y. A multi-signal mitochondria-targeted fluorescent probe for real-time visualization of cysteine metabolism in living cells and animals. Chem. Commun. 2018, 54, 11387–11390. [Google Scholar] [CrossRef] [PubMed]
  173. Zhang, B.; Zhang, H.; Zhong, M.; Wang, S.; Xu, Q.; Cho, D.-H.; Qiu, H. A novel off-on fluorescent probe for specific detection and imaging of cysteine in live cells and in vivo. Chin. Chem. Lett. 2020, 31, 133–135. [Google Scholar] [CrossRef]
  174. Yang, C.T.; Wang, Y.; Marutani, E.; Ida, T.; Ni, X.; Xu, S.; Chen, W.; Zhang, H.; Akaike, T.; Ichinose, F. Data-driven identification of hydrogen sulfide scavengers. Angew. Chem. Int. Ed. 2019, 58, 10898–10902. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Production and metabolic process of endogenous H2S.
Figure 1. Production and metabolic process of endogenous H2S.
Targets 02 00012 g001
Figure 2. Natural H2S donors.
Figure 2. Natural H2S donors.
Targets 02 00012 g002
Figure 3. Hydrolysis-triggered H2S donors.
Figure 3. Hydrolysis-triggered H2S donors.
Targets 02 00012 g003
Figure 4. Thiol-triggered H2S donors.
Figure 4. Thiol-triggered H2S donors.
Targets 02 00012 g004
Figure 5. Light-triggered H2S donors.
Figure 5. Light-triggered H2S donors.
Targets 02 00012 g005
Figure 6. Enzyme-triggered H2S donors.
Figure 6. Enzyme-triggered H2S donors.
Targets 02 00012 g006
Figure 7. H2S donors triggered by ROS.
Figure 7. H2S donors triggered by ROS.
Targets 02 00012 g007
Figure 8. Fluorescent probes related to H2S (1).
Figure 8. Fluorescent probes related to H2S (1).
Targets 02 00012 g008
Figure 9. Fluorescent probes related to H2S (2).
Figure 9. Fluorescent probes related to H2S (2).
Targets 02 00012 g009
Figure 10. Fluorescent probes related to H2S (3).
Figure 10. Fluorescent probes related to H2S (3).
Targets 02 00012 g010
Figure 11. Fluorescent probes related to H2S (4).
Figure 11. Fluorescent probes related to H2S (4).
Targets 02 00012 g011
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, J.; Jing, Q.; Gao, F.; Zhang, F.; Pei, D.; Di, D.; Hai, J. Review of Hydrogen Sulfide Based on Its Activity Mechanism and Fluorescence Sensing. Targets 2024, 2, 202-223. https://doi.org/10.3390/targets2030012

AMA Style

Zhang J, Jing Q, Gao F, Zhang F, Pei D, Di D, Hai J. Review of Hydrogen Sulfide Based on Its Activity Mechanism and Fluorescence Sensing. Targets. 2024; 2(3):202-223. https://doi.org/10.3390/targets2030012

Chicago/Turabian Style

Zhang, Jinlong, Quan Jing, Fei Gao, Fuxin Zhang, Dong Pei, Duolong Di, and Jun Hai. 2024. "Review of Hydrogen Sulfide Based on Its Activity Mechanism and Fluorescence Sensing" Targets 2, no. 3: 202-223. https://doi.org/10.3390/targets2030012

APA Style

Zhang, J., Jing, Q., Gao, F., Zhang, F., Pei, D., Di, D., & Hai, J. (2024). Review of Hydrogen Sulfide Based on Its Activity Mechanism and Fluorescence Sensing. Targets, 2(3), 202-223. https://doi.org/10.3390/targets2030012

Article Metrics

Back to TopTop